July 9, 2026 11:05 AM EDT FDA+Manufacturing FDA quietly stops releasing CRLs Zachary Brennan Senior Editor The FDA has paused its public release of pharma rejection letters as the agency seeks to avoid litigation around releasing the often sensitive information. The … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
76 words · extracted 12d agoread original ↗
comments(0)
5-min edit window · permanent after that